These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21681935)

  • 1. Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice.
    Rothman JA; Das R; Teachey DT; Paessler ME; Nichols KE
    Pediatr Blood Cancer; 2011 Dec; 57(7):1239-43. PubMed ID: 21681935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
    J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
    Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE
    Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis.
    Albeituni S; Oak N; Tillman HS; Stroh A; Keenan C; Bloom M; Nichols KE
    Front Immunol; 2023; 14():1137037. PubMed ID: 37228616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.
    Zinkernagel MS; Bolinger B; Krebs P; Onder L; Miller S; Ludewig B
    J Virol; 2009 Jan; 83(1):159-66. PubMed ID: 18945766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.
    Rood JE; Rao S; Paessler M; Kreiger PA; Chu N; Stelekati E; Wherry EJ; Behrens EM
    Blood; 2016 Jan; 127(4):426-35. PubMed ID: 26518437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Ailal F; Bousfiha A; Deswarte C; Oleaga-Quintas C; Casanova JL; Bustamante J; Liston A
    J Allergy Clin Immunol; 2019 Jun; 143(6):2215-2226.e7. PubMed ID: 30578871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH).
    Pachlopnik Schmid J; Ho CH; Diana J; Pivert G; Lehuen A; Geissmann F; Fischer A; de Saint Basile G
    Eur J Immunol; 2008 Nov; 38(11):3219-25. PubMed ID: 18991284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of itacitinib, fedratinib, and ruxolitinib in mouse models of hemophagocytic lymphohistiocytosis.
    Keenan C; Albeituni S; Oak N; Stroh A; Tillman HS; Wang Y; Freeman BB; Alemán-Arteaga S; Meyer LK; Woods R; Verbist KC; Zhou Y; Cheng C; Nichols KE
    Blood; 2024 Jun; 143(23):2386-2400. PubMed ID: 38446698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations.
    Ghosh S; Carmo M; Calero-Garcia M; Ricciardelli I; Bustamante Ogando JC; Blundell MP; Schambach A; Ashton-Rickardt PG; Booth C; Ehl S; Lehmberg K; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2018 Sep; 142(3):904-913.e3. PubMed ID: 29355678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients.
    Ishii K; Pouzolles M; Chien CD; Erwin-Cohen RA; Kohler ME; Qin H; Lei H; Kuhn S; Ombrello AK; Dulau-Florea A; Eckhaus MA; Shalabi H; Yates B; Lichtenstein DA; Zimmermann VS; Kondo T; Shern JF; Young HA; Taylor N; Shah NN; Fry TJ
    J Clin Invest; 2020 Oct; 130(10):5425-5443. PubMed ID: 32925169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.
    Gather R; Aichele P; Goos N; Rohr J; Pircher H; Kögl T; Zeiser R; Hengel H; Schmitt-Gräff A; Weaver C; Ehl S
    Eur J Immunol; 2020 Nov; 50(11):1770-1782. PubMed ID: 32419134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis.
    Albeituni S; Verbist KC; Tedrick PE; Tillman H; Picarsic J; Bassett R; Nichols KE
    Blood; 2019 Jul; 134(2):147-159. PubMed ID: 31015190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic lymphohistiocytosis: when the immune system runs amok.
    Janka G
    Klin Padiatr; 2009 Sep; 221(5):278-85. PubMed ID: 19707989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11.
    Sepulveda FE; Debeurme F; Ménasché G; Kurowska M; Côte M; Pachlopnik Schmid J; Fischer A; de Saint Basile G
    Blood; 2013 Jan; 121(4):595-603. PubMed ID: 23160464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current and future directions of pathologic analysis in hemophagocytic syndrome].
    Ishii E; Nagai K
    Nihon Rinsho; 2012 Jun; 70(6):1059-67. PubMed ID: 22690617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.
    Johnson TS; Terrell CE; Millen SH; Katz JD; Hildeman DA; Jordan MB
    J Immunol; 2014 Jan; 192(1):84-91. PubMed ID: 24259502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perforin and granzymes have distinct roles in defensive immunity and immunopathology.
    van Dommelen SL; Sumaria N; Schreiber RD; Scalzo AA; Smyth MJ; Degli-Esposti MA
    Immunity; 2006 Nov; 25(5):835-48. PubMed ID: 17088087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.